Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Fractional IPV in Infants
NCT04027036Phase 2Completed
- Sponsor
- Instituto Nacional de Saúde Doutor Ricardo Jorge
- Start
- Aug 2020
- Primary completion
- May 2022
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of trivalent inactivated polio vaccine in poliomyelitis, sponsored by Instituto Nacional de Saúde Doutor Ricardo Jorge. Started Aug 2020; status: completed.
02
Drugs
trivalent inactivated polio vaccine
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on NCT04027036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04027036.